Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results
ARAY Stock | USD 2.23 0.12 5.69% |
Slightly above 55% of Accuray Incorporated's investors are presently thinking to get in. The analysis of overall sentiment of trading Accuray Incorporated stock suggests that some investors are interested at this time. Accuray Incorporated's investing sentiment can be driven by a variety of factors including economic data, Accuray Incorporated's earnings reports, geopolitical events, and overall market trends.
Accuray |
Accuray Incorporated today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024.
Read at finance.yahoo.com
Accuray Incorporated Fundamental Analysis
We analyze Accuray Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accuray Incorporated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accuray Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Accuray Incorporated is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Accuray Incorporated Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accuray Incorporated stock to make a market-neutral strategy. Peer analysis of Accuray Incorporated could also be used in its relative valuation, which is a method of valuing Accuray Incorporated by comparing valuation metrics with similar companies.
Peers
Accuray Incorporated Related Equities
CTSO | Cytosorbents Crp | 6.59 | ||||
CUTR | Cutera | 6.52 | ||||
TELA | Tela Bio | 3.63 | ||||
NPCE | Neuropace | 3.41 | ||||
FNA | Paragon 28 | 3.20 | ||||
ANIK | Anika Therapeutics | 3.02 | ||||
KIDS | Orthopediatrics Corp | 2.32 | ||||
SIBN | Si Bone | 2.19 | ||||
CLPT | Clearpoint Neuro | 2.15 | ||||
OFIX | Orthofix Medical | 2.09 | ||||
SGHT | Sight Sciences | 2.05 | ||||
AORT | Artivion | 1.62 | ||||
BVS | Bioventus | 0.16 | ||||
AVNS | Avanos Medical | 0.10 | ||||
SRDX | SurModics | 0.23 | ||||
AXGN | Axogen | 1.21 | ||||
APYX | Apyx Medical | 4.73 |
Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.